Case Studies

MARKET EVALUATION OF OTC AND POM MEDICATION MARKET FOR BIOTECHNOLOGY FIRM

On August 12, 2014, In Case Studies, Tags ,,,
A small biotech firm with a novel chewable technology was looking to assess the global market for their technology. An understanding and quantification of both over-the-counter (OTC) and prescription-only medicine (POM) markets was required in a number of key global regions. Furthermore, the contribution of different formulation types to the markets was a necessary component of the evaluation. The client was ultimately looking for an assessment of the market to inform upcoming strategic decisions, and to potentially facilitate future investment options.

MARKET ACCESS AND OUTCOMES MODELLING FOR PHASE II ASSET

On July 16, 2014, In Case Studies,
Myocardial revascularisation is a life-saving intervention for patients suffering myocardial infarction (MI). However, tissue damage associated with revascularisation of the heart muscle represents a significant challenge for clinicians as it can lead to an acute inflammatory response; capillary leaks with major complications including atrial fibrillation; myocardial stunning; and an increased infarct size. A development-stage bio-pharmaceutical company has a novel peptide in development designed to limit the extent of tissue damage. The compound is entering Phase II clinical trials and has the potential to prevent or delay negative cardiac outcomes following revascularisation for a MI event. It therefore represents a potentially…

PROVIDING COMMERCIALISATION SUPPORT TO A UNIVERSITY INTELLECTUAL PROPERTY GROUP

On June 21, 2014, In Case Studies, Tags
An invention at a major academic institution has the potential to be useful in screening and profiling patients with a variety of conditions. The goal is to identify both the potential use, and the unmet needs in a number of managed care settings, in order to determine the inventions value and the likely clinical developments required. As a direct result of the development of a clear and thorough understanding of the various applications of this technology, and the availability of a robust market evaluation, the final output should enable the University to submit grant applications to fund proof-of-principle studies, as…

PUBLIC HEALTH BURDEN OF CHRONIC INFECTIOUS DISEASE FROM MIGRANT POPULATIONS

On June 12, 2014, In Case Studies, Tags ,
Chronic infectious diseases represent a significant burden to healthcare resources, especially in countries where conditions are endemic and regions deemed high risk by international bodies like the WHO. While prophylactic vaccines are available to combat many infections, an unknown number of asymptomtic carriers remain that were infected prior to vaccine availability. Carriers eventually develop life-threatening and costly conditions as a direct result of their primary infection. However, if diagnosed sufficiently early, patients can be treated and in some cases cleared entirely of their infection. An international pharmaceutical company wishes to understand the potential burden of a chronic disease by country,…

DUE DILIGENCE INSIGHT FOR INNOVATIVE OPHTHAMOLOGY PRODUCT

On February 12, 2014, In Case Studies, Tags
A global biopharmaceutical company is currently investigating a new opportunity, outside their main areas of focus and expertise. The therapy of interest has recently successfully completed Phase III clinical trials for an indication that is both poorly diagnosed and often untreated. Furthermore, this therapy is also a potential replacement for a highly invasive ophthalmologic procedure. The goal is to assist with a due diligence investigation through identifying both the potential use, and the unmet needs across regions within North America, Europe and Asia, by determining the therapy’s scope in terms of potential patients available. Additionally the company is looking to…